Featured Articles

  1. Using Mathematical Models To Improve Process Development 2/3/2023

    Explore the differences between statistical and mechanistic models along with their use in improving process development.

  2. How Distributed Automation And DPM Support Resilient Biomanufacturing 1/23/2023

    Learn how embracing digital transformation through the use of distributed automation and digital plant maturity can support productivity, efficiency, and resilience in biomanufacturing.

  3. Pursuing A “Biologic Revolution” With Vaxxinity's Mei Mei Hu 12/9/2022

    In a recent episode of The Business of Biotech, Vaxxinity's Mei Mei Hu explored how traditional vaccines and biologic therapies are converging to improve access to treatment on a global scale.

  4. Longhorn's Path To A Universal Influenza Vaccine 12/2/2022

    Thanks to the long-term planning of one biopharma family and some help from the U.S. Army, a universal influenza vaccine is coming soon to a clinical trial near you.

  5. Epigenomic Programming With Omega Therapeutics' Mahesh Karande 11/28/2022

    Designed at the intersection of engineering and biology, an exciting new drug mechanism aims to target and resolve a wide range of diseases at the pre-transcription level.

  6. 5 Translational Research Challenges On The Path To Patients 10/19/2022

    As a translational researcher, you’re paving an uncharted path toward exciting new possibilities in healthcare. Explore five difficulties translational researchers face when developing a new therapy.

  7. Investments, Capacity Expansion, And Improvements 10/7/2022

    An ongoing strategic growth plan is expanding our manufacturing capacity and services across geographies so we are able to better meet increased demand and have improved lead times for key products.

  8. Cytiva Strengthens Cell Line Development With CEVEC Acquisition 10/6/2022

    Global life sciences leader Cytiva has acquired CEVEC Pharmaceuticals, a leading German provider of high-performance cell line development and viral vector manufacturing technologies. CEVEC will further strengthen Cytiva's leading position in biomanufacturing solutions.

  9. Dry Powdered Medium Milling Equivalency Study 9/26/2022

    An assessment of the physical, chemical, and biological characteristics of representative complex media and feeds was made to compare pin mills and overall dry powdered medium manufacturing processes.

  10. Origin Equivalence Study: HyClone Characterized Fetal Bovine Serum (FBS) 9/26/2022

    Evaluate the cell culture and production performance of a fetal bovine serum brand with samples originating in three different countries, using three separate lots per country.